NCT06546579

Brief Summary

In this cross-sectional diagnostic study, healthy adults aged 18 and older with suspected, clinical, or confirmed scabies will be recruited. The objective is to determine if the sensitivity of self-collected skin samples for scabies diagnosis is non-inferior to professional sampling, and compare the sensitivity and specificity of the polymerase chain reaction assay (PCR) versus microscopy.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
144

participants targeted

Target at P75+ for early_phase_1

Timeline
Completed

Started Aug 2024

Shorter than P25 for early_phase_1

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 26, 2024

Completed
14 days until next milestone

First Posted

Study publicly available on registry

August 9, 2024

Completed
12 days until next milestone

Study Start

First participant enrolled

August 21, 2024

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2025

Completed
Last Updated

August 9, 2024

Status Verified

July 1, 2024

Enrollment Period

9 months

First QC Date

July 26, 2024

Last Update Submit

August 6, 2024

Conditions

Outcome Measures

Primary Outcomes (2)

  • The sensitivity of self-collected skin samples for diagnosing scabies

    The proportion of self-collected samples collected at the enrolment visit that are tested positive, divided by the total number of participants adjudged retrospectively to have had scabies at their enrolment visit, based on a composite clinical diagnosis.

    through study completion, an average of one year

  • The sensitivity of professionally-collected skin samples for diagnosing scabies

    The proportion of professionally-collected samples collected at the enrolment visit that are tested positive, divided by the total number of participants adjudged retrospectively to have had scabies at their enrolment visit, based on a composite clinical diagnosis.

    through study completion, an average of one year

Secondary Outcomes (4)

  • The sensitivity of skin scrapings for diagnosing scabies

    through study completion, an average of one year

  • The sensitivity of skin swabs for diagnosing scabies

    through study completion, an average of one year

  • The sensitivity and specificity of PCR on skin scraping for diagnosing active scabies infection

    through study completion

  • The sensitivity and specificity of microscopy on skin scraping for diagnosing active scabies infection

    through study completion, an average of one year

Other Outcomes (3)

  • Proportion of participants whose self-sampling location is judged appropriate

    through study completion, an average of one year

  • Motivation for self-collection of skin samples for scabies diagnostics

    through study completion, an average of one year

  • Demographic, clinical and epidemiological factors which influence the sensitivity of self-collected skin samples for scabies diagnosis.

    through study completion, an average of one year

Study Arms (1)

Experimental group

EXPERIMENTAL

All participants will be asked to perform self-sampling and irrespective of the result will receive current standard-of-care from their health care provider for their suspected scabies.

Diagnostic Test: Skin sampling

Interventions

Skin samplingDIAGNOSTIC_TEST

All individuals will self-collect skin samples and swabs and fill in a questionnaire. Subsequently, all individuals will see a professional. The professional will collect skin samples and swabs as well.

Experimental group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • years or older
  • Have either suspected scabies, clinical scabies or confirmed scabies (see table 1)
  • Providing informed consent (IC)

You may not qualify if:

  • Individuals not speaking or understanding the Dutch or English language.
  • Individuals who have been diagnosed with scabies in the last six weeks and had started treatment.
  • Individuals who have used ivermectin for other diagnoses than scabies in the last six weeks.
  • Individuals younger than 18 years.
  • Individuals with immunosuppressive conditions (see appendix A).
  • Any other condition, finding or situation which, in the opinion of the investigator, may significantly increase the risk to the individual because of participation in the study, affect the ability of the individual to participate in the study or impair interpretation of the study data.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Radboudumc

Nijmegen, Gelderland, 6525GA, Netherlands

RECRUITING

MeSH Terms

Conditions

Scabies

Condition Hierarchy (Ancestors)

Mite InfestationsEctoparasitic InfestationsSkin Diseases, ParasiticParasitic DiseasesInfectionsSkin Diseases, InfectiousSkin DiseasesSkin and Connective Tissue Diseases

Central Study Contacts

Matthew MC McCall, PhD

CONTACT

Saskia C van der Boor, PhD

CONTACT

Study Design

Study Type
interventional
Phase
early phase 1
Allocation
NA
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
SINGLE GROUP
Model Details: The study design is cross-sectional in terms of the diagnostic process, which aims to determine the presence of scabies in an individual at a specific point in time. All participants will undergo the same diagnostic procedures.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 26, 2024

First Posted

August 9, 2024

Study Start

August 21, 2024

Primary Completion

June 1, 2025

Study Completion

June 1, 2025

Last Updated

August 9, 2024

Record last verified: 2024-07

Data Sharing

IPD Sharing
Will not share

Locations